Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01913587
Other study ID # CIMI-13-01-21
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2013
Est. completion date March 2014

Study information

Verified date December 2021
Source Daegu Catholic University Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is to investigate the effectiveness of acupuncture for alleviating pain from Spinal Compression Fracture in Patients Treated with Nerve Block.


Description:

Spinal compression fracture is mainly caused by trauma, furthermore, in old age, osteoporosis increases the risk of spinal compression fracture. Nerve block is effective for the management of pain from inflammation or nerve root stimulation from spinal compression fracture. As one of alternative interventions, acupuncture is effective for controlling spinal compression fracture. This study aims to investigate that combination with acupuncture and nerve block may relieve spinal compression fracture-related pain versus nerve block alone.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date March 2014
Est. primary completion date March 2014
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria: - Vertebral compression fracture by trauma or osteoporosis - Minimum 15% height loss of vertebrae - Patient diagnosed with x-ray or computed tomography (CT) or magnetic resonance image (MRI) - Visual analogue scale (VAS) score of 5 or more - Age over 50 - 2 weeks from onset or more - Follow-up possible during the clinical trial - Written informed consent voluntarily Exclusion Criteria: - Within 2 weeks from onset - Pathological fracture due to malignancy/myeloma, osteomyelitis - Major retropulsion of bony segments into the spinal canal - Bone metabolic disease - Significant renal or hepatic disease - Hypersensitive reaction to acupuncture treatment - Senile dementia, impaired cognitive function or other cerebral disease, severe psychiatric or psychological disorders - Alcohol/drug abuse

Study Design


Intervention

Device:
Acupuncture
Acupuncture points are ST36, GB34 (bilateral), BL60 (bilateral), BL40 (bilateral), and 2 Back-su points (bilateral). Back-su points are selected as close as possible to pain region. Electroacupuncture will be performed at only 2 Back-su points (bilateral).
Procedure:
Nerve block
Epidural nerve block uses the mixture (10ml) of dexamethasone (10 mg) and bupivacaine (10 mg) dissolved in saline solution. Medial branch block uses mepivacaine (10 mg).

Locations

Country Name City State
Korea, Republic of Daegu Catholic University Medical Center Daegu Kyungsangbukdo

Sponsors (1)

Lead Sponsor Collaborator
Daegu Catholic University Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual analogue scale (VAS) The patients will be required to document 100mm pain VAS, where '0' represents 'no pain' and '100', 'unbearable pain'. The change of pain will be reported by comparing the mean VAS before treatment, after 3 week, and 5 week (2 weeks follow-up). Change from baseline to 5 weeks
Secondary Short form McGill pain questionnaire Evaluation will performed before treatment, after 3 week, and 5 week (2 weeks follow-up). Change from baseline to 5 weeks
Secondary Oswestry Disability Index (ODI) Evaluation will be performed before treatment, after 3 week, and 5 week (2 weeks follow-up). Change from baseline to 5 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT01281826 - Dual-energy CT in Detecting Bone Marrow Edema of Vertebral Compression Fractures N/A